Adding further credence to a direct role for SV2A in epilepsy pathogenesis is the recent identification of a homozygous mutation (R383Q) in a highly conserved residue of SV2A in an individual with intractable epilepsy, developmental and growth delay (Serajee and Huq, 2015). Here, SV2A is linked to epilepsy.